
AstraZeneca's CEO: Bringing Chinese innovation to patients worldwide
02:01 AstraZeneca recently announced an investment of $2.5 billion in Beijing to establish the pharmaceutical company's sixth global strategic R&D center, together with major research and manufacturing agreements. The new R&D center in Beijing …